Advertisement
U.S. markets closed

Streamline Health Solutions, Inc. (STRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.4800+0.0142 (+3.05%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close0.4658
Open0.4650
Bid0.4500 x 4000
Ask0.5099 x 2200
Day's Range0.4650 - 0.5000
52 Week Range0.2100 - 1.9000
Volume23,034
Avg. Volume99,983
Market Cap28.364M
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for STRM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Streamline Health Solutions, In
    The Argus Mid-Cap Model PortfolioSmall- and mid-cap stocks (SMID) have underperformed large-caps over the past 12 months, but may be in a better position to generate market-beating returns going forward. SMID companies tend to focus on domestic markets, so their businesses could be less disrupted by the fallout from global events. As well, the prices of SMID stocks generally are lower than the prices of large-caps. As well, there are long stretches in the record books when SMID stocks have outperformed large-caps. That said, SMID stocks can be risky. The standard deviation for monthly returns was 5.7% for SMID stocks over a 2003-2021 test period, versus 4.3% for large-caps. Still, despite the risks, diversified investors look to have exposure to small- and mid-caps based on the long-term performance record.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Insider Monkey

    20 Most Valuable Digital Health Companies In The US

    In this article, we will be taking a look at the 20 most valuable digital health companies in the US. If you are not interested in reading about the global health market, head straight to the 5 Most Valuable Digital Health Companies In The US. As of the latest data, several digital health companies stand […]

  • Insider Monkey

    Streamline Health Solutions, Inc. (NASDAQ:STRM) Q3 2023 Earnings Call Transcript

    Streamline Health Solutions, Inc. (NASDAQ:STRM) Q3 2023 Earnings Call Transcript December 14, 2023 Operator: Greetings, and welcome to the Streamline Health Solutions Third Quarter 2023 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jacob Goldberger. Thank you. Please go ahead. Jacob […]

  • Simply Wall St.

    Streamline Health Solutions Third Quarter 2024 Earnings: Misses Expectations

    Streamline Health Solutions ( NASDAQ:STRM ) Third Quarter 2024 Results Key Financial Results Revenue: US$6.13m (down...